Takeda Development Center Americas recalls

Takeda Development Center Americas appears in 2 official U.S. recall notices indexed by RecallRadar, most recently on 2018-11-21.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• AMITIZA (lubiprostone) capsules 8 mcg. 60-count bottle, Rx Only
  FDA Drug · Class III · 2018-11-21 · Takeda Development Center Americas
• Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Taked…
  FDA Drug · Class II · 2018-10-17 · Takeda Development Center Americas